Clinical Trials Logo

Tobacco Cessation clinical trials

View clinical trials related to Tobacco Cessation.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT05764343 Completed - Clinical trials for Bronchiectasis Adult

The Effect of Immediate Smoking Cessation Interventions for Smokers With Chronic Airway Diseases

Start date: November 15, 2022
Phase: N/A
Study type: Interventional

Smoking cessation support is provided by smoking cessation outpatient clinics in our country. Smokers with chronic airway diseases can also apply to these services by making an appointment from quit lines. Quit rates of that group patients were found to be similar to the general population. In novel smoking cessation support approaches immediate cessation support is reported to be more effective than routine practice. The sample in these studies consists of individuals who applied for lung health screening programmes. There is no study in the literature examining the effect of this immediate support on patients with chronic airway diseases' quit success. Our aim with this study is to examine impact of immediate cessation support by getting an appointment to the same cessation clinic instantly on our sample's cessation success.

NCT ID: NCT05095779 Completed - Tobacco Use Clinical Trials

Incentives for Smoking Cessation in Persistent Poverty Counties

Start date: March 9, 2022
Phase: N/A
Study type: Interventional

The proposed pilot project is designed to evaluate the feasibility and potential efficacy of offering small financial incentives for the completion of smoking cessation counseling and self-reported abstinence at follow-up among Oklahoma Tobacco Helpline (OTH) callers living in persistent poverty counties (PPCs). The study will enroll at least 160 adults who reside in any of the 16 persistent poverty counties in Oklahoma, who are seeking smoking cessation treatment through the OTH.

NCT ID: NCT04498858 Completed - Tobacco Cessation Clinical Trials

To Promote Tobacco Free Life in the Dental Practice in France

TOBAFREE-DP
Start date: April 14, 2021
Phase:
Study type: Observational

In France, 34% of the adult population is smoking every day. The links between smoking and the development of several chronic disorders is well established and smoking is directly implicated in most of the oral diseases such as cancers of the oral cavity. Thus, dentists have access to an area of the body that is actively affected and this gives them a central role in dispensing advice and support regarding smoking cessation. Dentists often cite issues such as lack of time or education as a reason for why they do not offer support for smoking cessation. A brief intervention can increase smoking cessation by 30 to 100% (ie 1-3% in absolute value). The "5A" approach integrates and extends the brief intervention. It consists in Asking about smoking status, Advising smokers of the benefit of stopping, Assessing motivation to quit, Assisting smokers in their quit attempt, Arranging follow-up with stop-smoking services. For practitioners who do not have enough time, a "3A" approach might be acceptable (Ask, Advice and Act) by providing details of local stop smoking services and/or prescribing nicotine replacement therapy (NRT). This very brief advice can be delivered in less than one minute. To investigators knowledge, the role of dentists in the French national tobacco-free program is not yet documented in France while since 2016, dentists can prescribe NRT with some products taken in charge by the French health insurance. An intervention taking part in the continuing professional development will be developed so the dentists fell legitimate, motivated and competent to talk with their patients about their tobacco consumption and to assist them in their smoking cessation process. This intervention based on the 5/3A approach and prescription of NRT will include a specific training and provision of management kit, with communication tools and network for appropriate references. Investigators hypothesize that 5/3A approach is feasible with adequate intervention in dental practices in France (dentists apply the approach to 90% of their patients) and that the format, the conditions, the barriers and the lever actions of its implementation are known.

NCT ID: NCT04251273 Completed - Tobacco Cessation Clinical Trials

Text Message Quit Vaping Intervention for Young Adults

Start date: December 19, 2019
Phase: N/A
Study type: Interventional

This research study, conducted by Truth Initiative, will help us learn how text messaging can help young adults between 18 and 24 years of age quit vaping.

NCT ID: NCT04198688 Completed - Cancer Clinical Trials

Effectiveness of Intensive Smoking Cessation Interventions in Patients With Cancer

Start date: January 3, 2006
Phase:
Study type: Observational

Smoking accounts for approximately 30% of total cancer deaths each year. Even though former studies show that persons with a cancer diagnosis are less likely to smoke than the general population up to 50% of people who smoke and have lung cancer do not stop smoking after their diagnosis or frequently relapse after smoking cessation. Continued smoking leads to increased all-cause mortality, increased cancer-specific mortality, and decreased quality of life. It is well-known that cancer patients are interested in smoking cessation therefore smoking cessation interventions play an important role in the management of people with cancer. This study will evaluate the effectiveness of an intensive smoking cessation interventions on cancer patients in real life. The project provides new knowledge about smokers diagnosed with cancer.

NCT ID: NCT03377738 Completed - Tobacco Cessation Clinical Trials

Effectiveness of the Spirometry Test as a Motivational Tool for Quitting Tobacco in Primary Care

Start date: May 2011
Phase: N/A
Study type: Interventional

The purpose of this study is analyze if spirometry is a motivational element for changes in the cessation phases of the tobacco habit, compared with not done spirometry.

NCT ID: NCT03096145 Completed - Tobacco Cessation Clinical Trials

Support Person Intervention to Promote a Smoking Helpline Among Under Resourced Smokers

Start date: May 1, 2017
Phase: N/A
Study type: Interventional

This pilot study is being done to adapt an effective 1 session phone coaching intervention for nonsmoking support persons to a low income population. This study will also pilot new intervention components including text messaging and health incentives. The goal of the intervention is for support persons to prompt their smoker to use quitline services. To see if these methods are effective, smokers in this study will be asked to complete assessments about their quit attempts and smoking status. The study will also evaluate if the smokers use quitline services or not. The preliminary findings will be used to provide data for an R01 NIH grant submission.

NCT ID: NCT03062709 Completed - Asthma Clinical Trials

A Study of Tobacco Smoke and Children With Respiratory Illnesses

Start date: March 12, 2017
Phase: N/A
Study type: Interventional

This study aims to assess the feasibility of using an intervention for environmental smoke exposure in children that uses cotinine testing results with written materials and telephone counseling for a potential future study of parents whose children are admitted with respiratory illnesses to The Barbara Bush Children's Hospital in Portland, Maine.

NCT ID: NCT02942745 Completed - Tobacco Cessation Clinical Trials

Testing the Effectiveness of a Betel Nut Cessation Program

BENIT
Start date: August 2016
Phase: N/A
Study type: Interventional

Areca nut, also known as betel nut, is the fourth most commonly consumed psychoactive substance in the world, following only alcohol, nicotine, and caffeine in prevalence of consumption. Although betel nut is chewed by approximately 600 million people globally, its use is concentrated in South Asia, Southeast Asia, and some Pacific Islands. Betel nut has been classified as a Group 1 carcinogen by the International Agency for Research on Cancer. Despite the global significance and carcinogenicity of betel nut, there has been very little behavioral or psychological research about betel nut chewing, and there has been no systematic research on the topic of betel nut cessation interventions. The current intervention builds directly upon the National Institutes of Health - National Cancer Institute's U54 University of Guam/University of Hawaii Cancer Center Comprehensive Partnership to Advance Health Equity. Previous data collected through the partnership suggest that betel nut chewers, like smokers, generally want and intend to quit, but do not have specific plans of how or when they will quit. In addition, most betel nut chewers in the partnership's previous study already have tried to quit on one or more occasions. The findings suggest that betel nut chewers could benefit from cessation programs modeled after smoking cessation programs. During 2014, partnership investigators conducted a feasibility study of the betel nut cessation program. The program was well received and yielded surprisingly high rates of self-reported betel nut cessation. Specific Aim 1. To test the efficacy of an intensive group-based betel nut cessation program. Specific Aim 2. To quantitatively determine the efficacy of the group-based betel nut cessation intervention trial using bio-verification.

NCT ID: NCT02510716 Completed - Tobacco Cessation Clinical Trials

Addressing Tobacco Use Disparities in Rural Older Adults Through an Innovative Mobile Phone Intervention

Start date: December 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the feasibility, acceptability and preliminary efficacy of a Scheduled Gradual Reduction (SGR) intervention via SMS (short message service) text messaging plus SMS Support Messages in decreasing smoking in an older adult rural population. The SGR group (n=20) will receive a four-week SGR program delivered via SMS text messages plus SMS support messages. The control group (n=20) will receive SMS support messages to aid in quitting.